GGrantIndex
Sort

261,768 grants matching gene therapy

Protection of Ischemic Myocardium

$2,212,132
Roberto Bolli · University Of Louisville · P01 · FY2006 · HL

MD Anderson Cancer Center SPORE in Gastrointestinal Cancer

$2,211,341
Scott Kopetz · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA

Communication Bridge: Optimizing an evidence-based intervention for individuals with primary progressive aphasia

$2,211,067
Emily J Rogalski · University Of Chicago · R01 · FY2025 · AG

Lupus nephritis: novel insights in the pathogenesis and treatment

$2,211,044
George C Tsokos · Beth Israel Deaconess Medical Center · P01 · FY2025 · AI

Genetics and Biology of Pancreatic Ductal Adenocarcinoma

$2,210,891
Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA

Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer

$2,210,645
Kornelia Polyak · Dana-Farber Cancer Inst · P50 · FY2022 · CA

Fungal genomics: population and systematic studies to map determinants of virulence, unique biology, and drug resistance

$2,210,640
Christina A Cuomo · Broad Institute, Inc. · U19 · FY2024 · AI

Epigenetic Markers of Complications and Metabolic Memory in the DCCT/EDIC cohort.

$2,210,571
Rama Natarajan · Beckman Research Institute/City Of Hope · DP3 · FY2015 · DK

Center on Antisocial Drug Dependence: The Genetics of HIV Risk Behaviors

$2,210,188
John K Hewitt · University Of Colorado · P60 · FY2009 · DA

Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury

$2,209,929
Pal Pacher · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2025 · AA

Gene therapy of cancer

$2,209,862
Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Adoptive Cell Transfer Immunotherapy of Cancer

$2,209,862
Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Studies in humans to delineate the basis for viral persistence

$2,209,658
David M. Margolis · Univ Of North Carolina Chapel Hill · U19 · FY2014 · AI

Host Pathogen Variation & TB Pathogenesis

$2,209,347
Thomas R Hawn · University Of Washington · U19 · FY2025 · AI

Airway inflammation and HLA-G in asthma

$2,209,345
Steven R White · University Of Chicago · U19 · FY2014 · AI

Novel Approaches for the Control of Microbial Pathogens

$2,209,322
Opendra Narayan · University Of Kansas Medical Center · P20 · FY2006 · RR

Genetic and Signaling Pathways in Epithelial Thyroid Cancer

$2,209,222
Matthew D Ringel · Ohio State University · P01 · FY2012 · CA

Protection of Ischemic Myocardium

$2,209,217
Roberto Bolli · University Of Louisville · P01 · FY2007 · HL

Predicting the emergence of antibiotic resistance through multi-omics approaches and Immune System-surveillan

$2,209,004
Tim Van Opijnen · Boston College · U01 · FY2017 · AI

Molecular Genetics Of Heritable Human Disorders

$2,208,533
Janice Chou · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2024 · HD

Developmental and Hyperactive Ras Tumor (DHART) SPORE

$2,208,392
David W. Clapp · Indiana University Indianapolis · U54 · FY2024 · CA

Sphingolipids in Cancer Biology and Therapy

$2,208,375
Yusuf Awni Hannun · State University New York Stony Brook · P01 · FY2025 · CA

Mechanisms of inherited neurodegenerative diseases

$2,208,322
Michael Ward · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS

Sleep, Aging and Circadian Rhythm Disorders

$2,207,980
Charles A Czeisler · Brigham And Women'S Hospital · P01 · FY2014 · AG

SPORE: Targeted Therapies for Glioma

$2,207,927
Tracy T Batchelor · Brigham And Women'S Hospital · P50 · FY2023 · CA